Notes Payable (Details Narrative) - USD ($) |
3 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|
Feb. 14, 2017 |
Feb. 10, 2017 |
Oct. 13, 2016 |
Oct. 07, 2016 |
Mar. 31, 2017 |
Mar. 31, 2016 |
Dec. 31, 2016 |
Nov. 14, 2016 |
|
Debt Instrument [Line Items] | ||||||||
Fair value of warrants | $ 1,000,000 | |||||||
Derivative liability | 2,338,790 | $ 1,583,103 | ||||||
Interest expense, net | 140,661 | $ 35,238 | ||||||
Accrued purchase obligation | 866,448 | |||||||
Executive Chairman [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Principal amount | $ 25,000 | $ 22,567 | ||||||
Due to related parties | $ 410,000 | |||||||
Debt instrument interest rate | 10.00% | 10.00% | ||||||
Proceeds from public offering | $ 10,000,000 | $ 10,000,000 | ||||||
Securities Purchase Agreement [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Non-assessable origination shares percentage | 48.00% | |||||||
Warrant to purchase of common stock description | (i) $0.70 per share, or (ii) the lowest daily closing price of the common stock during the ten days prior to delivery of the Origination Shares (subject to adjustment for stock splits), or (iii) 80% of the common stock offering price of the Public Offering, or (iv) 80% of the unit price offering price of the Public Offering (if applicable), or (v) the exercise price | (a) 80% of the per share price of the Common Stock in the Companys contemplated Public Offering, (b) $0.70 per share, (c) 80% of the unit price in the Public Offering (if applicable), d) the exercise price of any warrants issued in the Public Offering, or (e) the lowest conversion price, exercise price, or exchange price, of any security issued by the Company that is outstanding | ||||||
Number of shares of common stock outstanding percentage | 9.99% | |||||||
Aggregate additional advances received | 1,805,100 | |||||||
Repayment of purchase | $ 856,856 | |||||||
Principal amount | $ 64,286 | |||||||
Number of warrant to purchase of common stock shares | 1,150,142 | |||||||
Warrant exercise price per share | $ 0.70 | |||||||
Fair value of warrants | $ 150,142 | |||||||
Warrant term | 5 years | |||||||
One time additional advances received | $ 805,100 | |||||||
Placement agent fees and other issuance costs | 819,868 | |||||||
Debt discount | $ 51,756 | 18,213 | ||||||
Derivative liability | 44,795 | |||||||
Debt discount recognized over the term value | 801,655 | |||||||
Accrued purchase obligation | 866,448 | |||||||
Convertible Notes Payable [Member] | Board of Directors [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Principal amount | 495,000 | |||||||
Non-Convertible Note Payable [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Repayment to convertible note payable | $ 3,604 |